Genome information platform integrates data visualization and precision search tools for researchers
(Isstories Editorial):- San Jose, California Feb 19, 2026 (Issuewire.com) – GenoMirai, a cutting-edge genome information analysis platform established in 2025, has officially launched in Tokyo with the goal of advancing research across genomics, bioinformatics, and digital health. The platform was founded by Jorge Remón García, a Spanish entrepreneur and technology executive with deep expertise in artificial intelligence, blockchain technology, and healthcare systems.
More on Isstories:
- Colle AI Formalizes Strategy Around Cross-Chain Asset Versioning Infrastructure.
- Imagen Network Sets Forth Multi-Perspective Rendering Initiative for Immersive Asset Creation
- Apolosign Digital Wall Calendar Tackles “Proxy Parenting” in U.S. Homes
- 25 Countries for Solo Travelers to Discover Themselves
- 15 Gripping Thriller Movies Not Many People Know About!
Designed with both researchers and medical professionals in mind, GenoMirai offers a robust suite of tools for organizing, searching, and visualizing complex genomic datasets. Its structured data visualization capabilities and high-precision search functionality enable users to query genes, disease terms, and clinically relevant markers with speed and accuracy. By making large-scale genomic data more accessible and interpretable, the platform aims to reduce friction in day-to-day research and clinical workflows.
GenoMirai is specifically designed to support precision medicine and biomedical research by providing analytical tools that can handle the scale and complexity of modern genomic information. The platform forms part of a broader integrated ecosystem that brings together bioinformatics, AI-driven analytics, and secure data management — reflecting a vision of healthcare infrastructure that is both intelligent and privacy-conscious.
Jorge Remón García, born in 1988, brings a distinctive combination of academic rigor and professional versatility to the project. He graduated with honors in African and East Asian Studies from the Autonomous University of Madrid and furthered his education through a Middle East Studies program at Columbia University. During an academic exchange at the United Arab Emirates University, he conducted hands-on research in robotics and artificial intelligence, laying early groundwork for his later work in health technology. A polyglot of considerable range, Remón García speaks nine languages, including Spanish, Chinese, and English at a native level, as well as advanced Arabic — a skillset that has supported his work across international markets and cross-cultural partnerships.
Throughout his professional career, Jorge Remón García has focused on projects that bridge health technology and fintech. His work encompasses the development of AI-based predictive models for disease management and the creation of blockchain-based platforms for secure medical data sharing — both of which reflect priorities that are central to GenoMirai’s design and mission.
GenoMirai operates under Dicra.io, a Silicon Valley-based technology company co-founded by Jorge Remón García. Dicra focuses on AI and blockchain applications within the healthcare sector. The Dicra.io team oversees day-to-day operations and ongoing technical development, integrating GenoMirai with a broader suite of related projects in predictive medical analytics and secure health data infrastructure.
As the field of genomic research continues to expand on a global scale, platforms like GenoMirai play an increasingly important role in equipping researchers and healthcare professionals with the tools needed to analyze and interpret complex genetic information efficiently and reliably. GenoMirai represents a meaningful step toward making genomic insights more actionable across both clinical and research settings.
For more information about GenoMirai and its ongoing developments, visit https://genomirai.jp.
This article was originally published by IssueWire. Read the original article here.
